English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Assessment of Peripheral GABA Receptors for Local Pain Relief

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
Status
Sponsors
Aalborg University

Keywords

Abstract

The effect of peripheral GABAA receptor activation on pain and sensitivity in healthy human subjects has never been investigated. However, as earlier studies suggest that activation of peripheral GABAA receptors is anti-nociceptive in rats, it is important to determine if these findings can be translated into human subjects to determine if peripheral GABAA receptors are a viable target for future analgesic drug development.

Description

Subproject I This study will test if oral administration of GABA containing solutions will reduce the pain and sensitivity induced by application of capsaicin to the tongue of healthy human subjects. Thirty, pain-free men (n=15) and women (n=15) for the oral cavity study.

Subproject II This study will test the hypothesis that intramuscular injection of GABA alone will not be painful, but will reduce muscle pain sensitivity in healthy human subjects. Thirty, pain-free men (n=15) and women (n=15) will be recruited for the intramuscular GABA injection studies

Subproject III This study will test the hypothesis that intramuscular injection of GABA with glutamate will decrease the intensity of glutamate-evoked muscle pain in healthy human subjects. Thirty, pain-free men (n=15) and women (n=15) will be recruited for the intramuscular glutamate and GABA injection studies.

Dates

Last Verified: 12/31/2017
First Submitted: 10/05/2016
Estimated Enrollment Submitted: 10/06/2016
First Posted: 10/09/2016
Last Update Submitted: 01/07/2018
Last Update Posted: 01/09/2018
Actual Study Start Date: 09/30/2016
Estimated Primary Completion Date: 11/30/2018
Estimated Study Completion Date: 11/30/2019

Condition or disease

Pain

Intervention/treatment

Drug: GABA oral solution

Drug: Intramuscular GABA

Drug: Pain modulation

Phase

-

Arm Groups

ArmIntervention/treatment
Experimental: GABA oral solution
This study will test if oral administration of GABA containing solutions will reduce the pain and sensitivity induced by application of capsaicin to the tongue of healthy human subjects.
Drug: GABA oral solution
Oral mouth wash containing either GABA, lidocaine or distilled water will be used to decrease burning tongue pain produced by capsaicin
Experimental: Intramuscular GABA
This study will test the hypothesis that intramuscular injection of GABA alone will not be painful, but will reduce muscle pain sensitivity in healthy human subjects.
Drug: Intramuscular GABA
The effect of intramuscular injection of GABA or lorazepam will be compared with buffered isotonic saline
Experimental: Pain modulation
This study will test the hypothesis that intramuscular injection of GABA with glutamate will decrease the intensity of glutamate-evoked muscle pain in healthy human subjects.
Drug: Pain modulation
The effect of GABA alone or in combination with lorazepam on muscle pain produced by intramuscular injection of glutamate will be assessed.

Eligibility Criteria

Ages Eligible for Study 20 Years To 20 Years
Sexes Eligible for StudyAll
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria:

- Aged 20-40 years

- Free from ongoing or chronic pain

- Adequate conversational English

Exclusion Criteria:

- Pregnancy or intent to become pregnant, breast feeding

- Signs or symptoms of any serious systemic diseases

- Current malignancies

- High blood pressure

- Requirement for chronic administration of psychiatric, analgesic or other medications that might influence their response to pain

- Frequent recreational drug or alcohol use

- Previous neurologic, musculoskeletal or mental illnesses

- Lack of ability to cooperate

Outcome

Primary Outcome Measures

1. Pain Intensity Rating [continuously for 95 minutes]

visual analogue scale

Secondary Outcome Measures

1. Jaw Function Tests [every 5 min for 50 minutes]

maximal jaw opening, maximal bite force

2. Quantitative Sensory testing [every 10 min for 90 min]

Pressure detection and pain threshold, thermal detection and pain threshold

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge